Monogenic disorders of the pancreatic &bgr;-cell: personalizing treatment for rare forms of diabetes and hypoglycemia

Author： van de Bunt Martijn   Gloyn Anna L  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.4, Iss.3, 2007-08, pp. : 247-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Conversion of embryonic stem cells into pancreatic &bgr;-cell surrogates guided by ontogeny

By Lees Justin G   Tuch Bernard E  

Regenerative Medicine, Vol. 1, Iss. 3, 2006-05 ,pp. : 327-336

Future Medicine

Access to resources Recommend Favorite

Monogenic diabetes: the treatment options

By  

DIABETIC MEDICINE, Vol. 32, Iss. 4, 2015-04 ,pp. : 429-430

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pluripotent stem cell-derived pancreatic &bgr;-cells: potential for regenerative medicine in diabetes

By Kao Der-I   Chen Shuibing  

Regenerative Medicine, Vol. 7, Iss. 4, 2012-07 ,pp. : 583-593

Future Medicine

Access to resources Recommend Favorite

Personalizing rare disease research: how genomics is revolutionizing the diagnosis and treatment of rare disease

By Dolled-Filhart Marisa P   Lordemann Amanda   Dahl William   Haraksingh Rajini Rani   Ou-Yang Chih-Wen   Lin Jimmy Cheng-Ho  

Personalized Medicine, Vol. 9, Iss. 8, 2012-11 ,pp. : 805-819

Future Medicine

Access to resources Recommend Favorite

Pancreatic β‐cell identity in diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. S1, 2016-09 ,pp. : 110-116

John Wiley & Sons Inc

Access to resources Recommend Favorite